GEOFFREY M. PARKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Viracta Therapeutics, Inc.

Filing Date Source Excerpt
2016-04-25 Geoffrey M. Parker joined the Board and the Audit Committee on March 23, 2016. No compensation is listed for 2015.
2017-04-20 Geoffrey M. Parker served as the Executive Vice President and Chief Financial Officer of Anacor Pharmaceuticals, Inc. ... The Board has concluded that Mr. Parker should serve on our Board based on his financial expertise. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2016. Geoffrey M. Parker received total compensation of $69,788.

Data sourced from SEC filings. Last updated: 2026-03-09